Emerging Nanomedicines for Diabetes Mellitus Theranostics provides readers with information on the development of efficacious nanomedicines as potential theranostic agents for diabetes. The book discusses the application of various novel nanomaterials and nanocomposites for targeted delivery of insulin, glucose sensing, including nano-tattoos as glucose monitors, biosynthesized nanoparticles for diabetes treatment, and pre-clinical and clinical assays to evaluate the efficacy of nanomedicines for diabetes treatment. This is an important references source for materials scientists, pharmaceutical scientists and biomedical engineers who want to increase their understanding of how nanotechnology is being used to improve diabetes treatment.
Diabetes has emerged as one of the most common diseases associated with lifestyle choices in the modern world, with significant mortality rates. Conventional treatment methods mainly involve insulin-based therapies. However, insulin therapy possesses several limitations such as weight gain and hypoglycemia. Thus, advanced research in nanomedicine is targeting the development of new and improved diagnostics and treatment methods for diabetes.
1. Cover image - p. Cover 2. Title page - p. iii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. About the authors - p. ix 6. Preface - p. xi 7. Acknowledgments - p. xiii 8. Chapter 1. The current state of diabetes treatment - p. 1 9. Chapter 2. Nanoparticles and nanocomposites for controlled delivery of insulin - p. 33 10. Chapter 3. Nanomaterials as glucose sensors for diabetes monitoring - p. 59 11. Chapter 4. Nano-tattoos—a novel approach for glucose monitoring and diabetes management - p. 97 12. Chapter 5. Metal and metal oxide nanoparticles: synthesis, properties, and applications as nanomedicines for diabetes treatment - p. 111 13. Chapter 6. Biosynthesized nanoparticles for diabetes treatment - p. 143 14. Chapter 7. Cytotoxicity of nanoparticles toward diabetic cell models - p. 173 15. Chapter 8. In vivo studies of nanoparticles in diabetic models - p. 199 16. Chapter 9. Preclinical and clinical evaluation of nanodrugs for diabetes treatment - p. 225 17. Chapter 10. Future of nanoparticles, nanomaterials, and nanomedicines in diabetes treatment - p. 247 18. Index - p. 261
Emerging Nanomedicines for Diabetes Mellitus Theranostics provides readers with information on the development of efficacious nanomedicines as potential theranostic agents for diabetes. The book discusses the application of various novel nanomaterials and nanocomposites for targeted delivery of insulin, glucose sensing, including nano-tattoos as glucose monitors, biosynthesized nanoparticles for diabetes treatment, and pre-clinical and clinical assays to evaluate the efficacy of nanomedicines for diabetes treatment. This is an important references source for materials scientists, pharmaceutical scientists and biomedical engineers who want to increase their understanding of how nanotechnology is being used to improve diabetes treatment.
Diabetes has emerged as one of the most common diseases associated with lifestyle choices in the modern world, with significant mortality rates. Conventional treatment methods mainly involve insulin-based therapies. However, insulin therapy possesses several limitations such as weight gain and hypoglycemia. Thus, advanced research in nanomedicine is targeting the development of new and improved diagnostics and treatment methods for diabetes.
1. Cover image - p. Cover 2. Title page - p. iii 3. Table of Contents - p. iii 4. Copyright - p. iv 5. About the authors - p. ix 6. Preface - p. xi 7. Acknowledgments - p. xiii 8. Chapter 1. The current state of diabetes treatment - p. 1 9. Chapter 2. Nanoparticles and nanocomposites for controlled delivery of insulin - p. 33 10. Chapter 3. Nanomaterials as glucose sensors for diabetes monitoring - p. 59 11. Chapter 4. Nano-tattoos—a novel approach for glucose monitoring and diabetes management - p. 97 12. Chapter 5. Metal and metal oxide nanoparticles: synthesis, properties, and applications as nanomedicines for diabetes treatment - p. 111 13. Chapter 6. Biosynthesized nanoparticles for diabetes treatment - p. 143 14. Chapter 7. Cytotoxicity of nanoparticles toward diabetic cell models - p. 173 15. Chapter 8. In vivo studies of nanoparticles in diabetic models - p. 199 16. Chapter 9. Preclinical and clinical evaluation of nanodrugs for diabetes treatment - p. 225 17. Chapter 10. Future of nanoparticles, nanomaterials, and nanomedicines in diabetes treatment - p. 247 18. Index - p. 261
